Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.1785
-0.0097 (-5.15%)
Jun 10, 2026, 1:50 PM EDT - Market open
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $3.56 million as of June 10, 2026. Its market cap has decreased by -18.09% in one year.
Market Cap
3.56M
Enterprise Value
849.74K
1-Year Change
-18.09%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $3.56M, a decrease of -98.28%. That is a compound annual growth rate of -64.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 4.16M | 62.06% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 5.05M |
| Pulmatrix | 4.86M |
| GeoVax Labs | 4.77M |
| Dermata Therapeutics | 4.75M |
| Galmed Pharmaceuticals | 4.58M |
| Soligenix | 4.57M |
| Alzamend Neuro | 4.22M |
| Clearmind Medicine | 4.06M |